Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases

Drug Discovery Today

Volumn 13, Issue 5-6, 2008, Pages 234-239

  Sanger, Gareth J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMCINAL; ERYTHROMYCIN; G PROTEIN COUPLED RECEPTOR 39; GASTROINTESTINAL HORMONE; GHRELIN; HORMONE RECEPTOR; KOS 2187; MITEMCINAL; MOTILIN; MOTILIN ASSOCIATED PEPTIDE; OBESTATIN; PEPTIDE; PF 04548043; PLACEBO; PREPROGHRELIN; PREPROMOTILIN; PROKINETIC AGENT; TZP 101; TZP 102; UNCLASSIFIED DRUG;

DIABETES MELLITUS; DRUG STRUCTURE; DYSPEPSIA; GASTROINTESTINAL DISEASE; HORMONE ACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE CONTRACTION; NERVE CELL; NONHUMAN; PROTEIN TARGETING; REPEATED DRUG DOSE; REVIEW; STOMACH PARESIS;

EID: 40649105561     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.10.024     Document Type: Review

References (65)

1. Z. Itoh Motilin and clinical application Peptides 18 1997 593 608
2. S.D. Feighner Receptor for motilin identified in the human gastrointestinal system Science 284 1999 2184 2188
3. E. Husebye The patterns of small bowel motility: physiology and implications in organic disease and functional disorders Neurogastroenterol. Motil. 11 1999 141 161
4. T.L. Peeters Potential of motilides in the treatment of hypomotility syndromes M.K. Herbert P. Holzer N. Roewer Problems of the Gastrointestinal Tract in Anaesthesia 1999 Springer-Verlag Berlin, Heidelberg 39 51
5. K. Toshinai Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor Endocrinology 147 2006 2306 2314
6. C. Folwaczny Ghrelin and motilin: two sides of one coin? Eur. J. Endocrinol. 144 2001 R1 R3
7. T.L. Peeters Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders Curr. Opin. Pharmacol. 6 2006 553 558
8. N.B. Dass The rabbit motilin receptor: molecular characterisation and pharmacology Br. J. Pharmacol. 140 2003 948 954
9. J.A. Rudd Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin Neurosci. Lett. 392 2006 79 83
10. A. Bassil Prokineticin-2, motilin, ghrelin and metoclopramide: prokinetic utility in mouse stomach and colon Eur. J. Pharmacol. 524 2005 138 144
11. J. Hill Molecular, functional and cross-species comparisons between the receptors for the prokinetic neuropeptides, motilin and ghrelin Gastroenterology 122 Suppl. 1 2002 A54
12. X. Feng Motilin activates neurons in the rat amygdale and increases gastric motility Peptides 28 2007 625 631
13. L. Thielemans Desensitization of the human motilin receptor by motilides J. Pharmacol. Exp. Ther. 313 2005 1397 1405
14. E. Takeshita Molecular characterisation and distribution of motilin family receptors in the human gastrointestinal tract J. Gastroenterol. 41 2006 223 230
15. E. Mochiki Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs Am. J. Physiol. 272 1997 G224 G232
16. I. Depoortere Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum J. Pharmacol. Exp. Ther. 305 2003 660 667
17. E.M. Jarvie Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro Br. J. Pharmacol. 150 2007 455 462
18. V. Annese Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus Aliment. Pharmacol. Ther. 11 1997 599 603
19. A. Sturm Prokinetics in patients with gastroparesis: a systematic analysis Digestion 60 1999 422 427
20. B. Coulie Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans Gut 43 1998 395 400
21. R. Cuomo Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways Am. J. Gastroenterol. 101 2006 804 811
22. M.A. Boivin Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects Pharmacotherapy 23 2003 5 8
23. M.A. Ritz Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill Intensive Care Med. 31 2005 949 954
24. R.D. Richards The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin Am. J. Gastroenterol. 88 1993 203 207
25. R. Dhir J.E. Richter Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis J. Clin. Gastroenterol. 38 2004 237 242
26. I. Depoortere Distribution and subcellular localization of motilin binding sites in the rabbit brain Brain Res. 777 1997 103 109
27. C. Yanaihara Motilin-, substance P- and somatostatin-like immunoreactivities in extracts from dog, tupaia and monkey brain and GI tract Adv. Exp. Med. Biol. 106 1978 269 283
28. J.K. Dibaise E.M. Quigley Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one centre's experience J. Clin. Gastroenterol. 28 1999 131 134
29. H. Abrahamsson Treatment options for patients with severe gastroparesis Gut 56 2007 877 883
30. C.V. Hawkyard R.J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J. Antimicrobial. Chemother. 59 2007 347 358
31. N.J. Talley Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial Aliment. Pharmacol. Ther. 14 2000 1653 1661
32. N.J. Talley Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial Gut 49 2001 395 401
33. V.B. Nieuwenhuijs The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats Eur. J. Clin. Invest. 29 1999 33 40
34. J. Tack T. Peeters What comes after macrolides and other motilin stimulants? Gut 49 2001 317 318
35. E. Marsault Potent macrocyclic antagonists to the motilin receptor presenting novel unnatural amino acids Bioorg. Med. Chem. Lett. 17 2007 4187 4190
36. A.F. Leite-Moreira J.-B. Soares Physiological, pathophysiological and potential therapeutic roles of ghrelin Drug Discov. Today 12 2007 276 288
37. A.J. Page Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents Am. J. Physiol. 292 2007 G1376 G1384
38. N.B. Dass Growth hormone secretagogue receptors in the rat and human gastrointestinal tract and the effects of ghrelin Neuroscience 120 2003 443 453
39. T. Edholm Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons Reg. Peptides 121 2004 25 30
40. C.W. le Roux Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy J. Clin. Endocrinol. Metabol. 90 2005 4521 4524
41. W.A. Banks Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure J. Pharmacol. Exp. Ther. 302 2002 822 827
42. T. Brzozowski Exogenous and endogenous ghrelin in gastroprotection against stress-induced damage Reg. Peptides 120 2004 39 51
43. Y. Shimizu Increased plasma ghrelin level in lung cancer cachexia Clin. Cancer Res. 9 2003 774 778
44. L. Trudel Two new peptides to improve post-operative gastric ileus in dog Peptides 24 2003 531 534
45. B.Y. De Winter Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice Neurogastroenterol. Motil. 16 2004 439 446
46. Y.-L. Liu Ghrelin alleviates cancer chemotherapy-associated dyspepsia in mice Cancer Chemother. Pharmacol. 58 2006 326 333
47. N.M. Neary Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial J. Clin. Endocrinol. Metabol. 89 2004 2832 2836
48. E.T. Vestergaard Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects Am. J. Physiol. 292 2007 E1829 E1836
49. J.V. Zhang Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake Science 310 2005 986 996
50. J.V. Zhang Response to comment on Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake Science 315 2007 766
51. W.K. Samson Obestatin acts in brain to inhibit thirst Am. J. Physiol. 292 2007 R637 R643
52. A.K. Bassil Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract Br. J. Pharmacol. 150 2007 58 64
53. B. De Smet Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents Neurogastroenterol. Motil. 19 2007 211 217
54. S.L. Dun Distribution and biological activity of obestatin in the rat J. Endocrinol. 191 2006 481 489
55. D. Moechars Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse Gastroenterology 131 2006 1131 1141
56. K.L. Egerod GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver and white adipose tissue Mol. Endocrinol. 21 2007 685 698
57. Z. Huang Isolation and sequence of cDNA encoding the motilin precursor from monkey intestine. Demonstration of the motilin precursor in the monkey brain FEBS Lett. 435 1998 149 152
58. R.W. McCallum Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial Aliment. Pharmacol. Ther. 26 2007 107 116
59. Peeters, T.L. (2006) New motilin agonists: a long and winding road
60. S. Gonlachanvit Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients Dig. Dis. Sci. 48 2003 488 497
61. K. Maganti Oral erythromycin and symptomatic relief of gastroparesis: a systematic review Am. J. Gastroenterol. 98 2003 259 263
62. N. Carbonell Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial Am. J. Gastroenterol. 101 2006 1211 1215
63. H. Levy Transpyloric feeding tube placement in critically ill patients using electromyogram and erythromycin infusion Chest 125 2004 587 591
64. Madsen, J.L. et al. (2007) Ghrelin agonist (TZP-101) gastroprokinetic action in diabetic patients with gastroparesis: a pilot study. American Diabetes Association (Abstract 599-P)
65. F. Venkovak Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus Dig. Dis. Sci. 52 2007 2241 2248